{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:55:38Z","timestamp":1782579338786,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Statins are an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). Growing evidence indicates that statins may have an anti-inflammatory effect. Whether genetically proxied HMGCR inhibition can reduce the risk of ankylosing spondylitis is unknown. We constructed an HMGCR genetic score comprising nearly randomly inherited variants significantly associated with LDL cholesterol levels within \u00b1 100 kb from HMGCR to proxy for inhibition of HMGCR. We also constructed PCSK9 and NPC1L1 scores as well as the LDL polygenetic score to proxy for the inhibition of these drug targets as well as serum LDL cholesterol levels, respectively. We then compared the associations of these genetic scores with the risk of ankylosing spondylitis. Of 33,998 participants in the primary cohort, 12,596 individuals had been diagnosed with ankylosing spondylitis. Genetically proxied inhibition of HMGCR scaled to per mmol\/L decrease in LDL cholesterol levels by the HMGCR score was associated with a lower risk of ankylosing spondylitis (OR, 0.57; 95% CI, 0.38\u20130.85; <jats:italic>P<\/jats:italic> value = 5.7 \u00d7 10<jats:sup>\u20133<\/jats:sup>). No significant association with ankylosing spondylitis was observed for the PCSK9 score (OR, 0.89; 95% CI, 0.68\u20131.16) and the NPC1L1 score (OR, 1.50; 95% CI, 0.39\u20135.77). For the LDL score, genetically determined per mmol\/L decrease in LDL cholesterol levels led to a reduced risk of ankylosing spondylitis (OR, 0.64; 95% CI, 0.43\u20130.94), with significant heterogeneity and pleiotropy in the estimate. Exploratory analyses showed that genetically proxied inhibition of HMGCR appeared to have a similar effect to long-term statin therapy in modifying the risk of coronary artery disease and type 2 diabetes, suggesting that the HMGCR score might be a reliable model to assess the effect of statin. Genetically proxied inhibition of HMGCR was associated with a decreased risk of ankylosing spondylitis. This mechanism-based estimate was in line with existing observations suggesting the clinical benefits of statin therapy for ankylosing spondylitis.<\/jats:p>","DOI":"10.3389\/fcell.2021.731072","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:30:00Z","timestamp":1633577400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhenyu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.","volume":"18","author":"Antonopoulos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","article-title":"Sample size and power calculations in mendelian randomization with a single instrumental variable and a binary outcome.","volume":"43","author":"Burgess","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7325","article-title":"Use of mendelian randomisation to assess potential benefit of clinical intervention.","volume":"345","author":"Burgess","year":"2012","journal-title":"BMJ: Br. Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","article-title":"Inferring causal relationships between risk factors and outcomes from genome-wide association study data.","volume":"19","author":"Burgess","year":"2018","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cca.2014.08.040","article-title":"Vitamin D in ankylosing spondylitis: review and meta-analysis.","volume":"438","author":"Cai","year":"2015","journal-title":"Clin. Chim Acta"},{"key":"B11","first-page":"RA245","article-title":"Influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in treating autoimmune disorders.","volume":"16","author":"Chalubinski","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07743-4","article-title":"GWAS identifies 14 loci for device-measured physical activity and sleep duration.","volume":"9","author":"Doherty","year":"2018","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis.","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial Mendelian randomization study.","volume":"65","author":"Ference","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes.","volume":"375","author":"Ference","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10067-015-2912-3","article-title":"Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.","volume":"34","author":"Garg","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/bioinformatics\/bty147","article-title":"A Bayesian framework for multiple trait colocalization from summary association statistics.","volume":"34","author":"Giambartolomei","year":"2018","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study.","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0795-y","article-title":"Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.","volume":"17","author":"Ikdahl","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat. Genet."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02662-2","article-title":"Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels.","volume":"9","author":"Jiang","year":"2018","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008038","article-title":"Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis.","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00296-017-3741-2","article-title":"Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis.","volume":"37","author":"Lin","year":"2017","journal-title":"Rheumatol. Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis.","volume":"27","author":"Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","article-title":"Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.","volume":"51","author":"Liu","year":"2019","journal-title":"Nat. Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41562-019-0557-y","article-title":"GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture.","volume":"3","author":"Matoba","year":"2019","journal-title":"Nat. Hum. Behav."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1970-3","article-title":"Alcohol consumption as a predictor of the progression of spinal structural damage in axial spondyloarthritis: data from the Catholic Axial Spondyloarthritis COhort (CASCO).","volume":"21","author":"Min","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardizatlon of vitreal inflammatory activity in intermediate and posterior uveitis.","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jphys.2016.11.009","article-title":"Behaviour change intervention increases physical activity, spinal mobility and quality of life in adults with ankylosing spondylitis: a randomised trial.","volume":"63","author":"O\u2019Dwyer","year":"2017","journal-title":"J. Physiotherapy"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211253","article-title":"Survival benefit of statin use in ankylosing spondylitis: a general population-based cohort study.","volume":"76","author":"Oza","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat. Methods Med. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/art.39114","article-title":"Rosuvastatin-Induced carotid plaque regression in patients with inflammatory joint diseases: the rosuvastatin in rheumatoid arthritis, ankylosing spondylitis and other inflammatory joint diseases study.","volume":"67","author":"Rollefstad","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrrheum.2016.103","article-title":"Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.","volume":"12","author":"Semb","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme a reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement.","volume":"316","year":"2016","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044503","article-title":"Statin therapy might be beneficial for patients with ankylosing spondylitis.","volume":"65","author":"van Denderen","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1136\/annrheumdis-2016-209176","article-title":"Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy.","volume":"75","author":"van der Valk","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140353","article-title":"Current smoking is associated with incident ankylosing spondylitis \u2014 the HUNT population-based norwegian health study.","volume":"41","author":"Videm","year":"2014","journal-title":"J. Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","article-title":"Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities.","volume":"46","author":"Walker","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and Inflammation in atherosclerosis.","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","article-title":"Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase.","volume":"67","author":"W\u00fcrtz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04951-w","article-title":"Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes.","volume":"9","author":"Xue","year":"2018","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309499","article-title":"Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort.","volume":"102","author":"Yang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.2020.0150","article-title":"Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer.","volume":"323","author":"Yarmolinsky","year":"2020","journal-title":"JAMA"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.731072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:30:04Z","timestamp":1633577404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.731072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":48,"alternative-id":["10.3389\/fcell.2021.731072"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.731072","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"article-number":"731072"}}